123 related articles for article (PubMed ID: 24184699)
1. CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Sanseverino I; Rinaldi AO; Purificato C; Cortese A; Millefiorini E; Gessani S; Gauzzi MC
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():102-5. PubMed ID: 24184699
[TBL] [Abstract][Full Text] [Related]
2. 1,25(OH)
Sanseverino I; Rinaldi AO; Purificato C; Cortese A; Millefiorini E; Gauzzi MC
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047690
[TBL] [Abstract][Full Text] [Related]
3. The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation.
Turner AG; Hanrath MA; Morris HA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():114-8. PubMed ID: 24125735
[TBL] [Abstract][Full Text] [Related]
4. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
5. 1α,25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study.
Ferreira GB; Overbergh L; Verstuyf A; Mathieu C
J Steroid Biochem Mol Biol; 2013 Jul; 136():160-5. PubMed ID: 23098690
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
Pedersen LB; Nashold FE; Spach KM; Hayes CE
J Neurosci Res; 2007 Aug; 85(11):2480-90. PubMed ID: 17600374
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D-mediated immune regulation in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
J Neurol Sci; 2011 Dec; 311(1-2):23-31. PubMed ID: 21723567
[TBL] [Abstract][Full Text] [Related]
8. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
[TBL] [Abstract][Full Text] [Related]
9. Treatment with 1,25(OH)2D3 induced HDAC2 expression and reduced NF-κB p65 expression in a rat model of OVA-induced asthma.
Zhou Y; Wang GF; Yang L; Liu F; Kang JQ; Wang RL; Gu W; Wang CY
Braz J Med Biol Res; 2015 Jul; 48(7):654-64. PubMed ID: 25923460
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcitriol and its analogues on interaction of MCP-1 and monocyte derived dendritic cells in vitro.
Zhu KJ; Shen QY; Zheng M; Mrowietz U
Acta Pharmacol Sin; 2001 Jan; 22(1):62-5. PubMed ID: 11730564
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis.
Bartosik-Psujek H; Tabarkiewicz J; Pocinska K; Stelmasiak Z; Rolinski J
Mult Scler; 2010 Dec; 16(12):1513-6. PubMed ID: 20739336
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory Effects of 1,25-Dihydroxyvitamin D
Lee WP; Willekens B; Cras P; Goossens H; Martínez-Cáceres E; Berneman ZN; Cools N
J Immunol Res; 2016; 2016():5392623. PubMed ID: 27703987
[TBL] [Abstract][Full Text] [Related]
15. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
Thewissen K; Nuyts AH; Deckx N; Van Wijmeersch B; Nagels G; D'hooghe M; Willekens B; Cras P; Eijnde BO; Goossens H; Van Tendeloo VF; Stinissen P; Berneman ZN; Hellings N; Cools N
Mult Scler; 2014 Apr; 20(5):548-57. PubMed ID: 24057429
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells.
Huang Y; Zhao Y; Ran X; Wang C
Mol Med Rep; 2014 Mar; 9(3):813-8. PubMed ID: 24366217
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Correale J; Ysrraelit MC; Gaitán MI
J Immunol; 2010 Oct; 185(8):4948-58. PubMed ID: 20855882
[TBL] [Abstract][Full Text] [Related]
19. The ASAP2 gene is a primary target of 1,25-dihydroxyvitamin D3 in human monocytes and macrophages.
Seuter S; Ryynänen J; Carlberg C
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():12-8. PubMed ID: 23999061
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes.
Marcotorchino J; Gouranton E; Romier B; Tourniaire F; Astier J; Malezet C; Amiot MJ; Landrier JF
Mol Nutr Food Res; 2012 Dec; 56(12):1771-82. PubMed ID: 23065818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
